Related Experiment Videos
[Future pain treatment].
L J Rygh1, T H Fagerlund, F Svendsen
1Fysiologisk institutt og Locus for Nevrovitenskapene Det medisinske fakultet Universitetet i Bergen Arstadveien 19 5009 Bergen. lars.jorgen.rygh@fys.uib.no
Summary
Advances in genetics and molecular biology have revealed new targets for pain relief. Understanding the mechanisms of chronic and acute pain allows for the development of novel analgesics with fewer side effects.
Area of Science:
- Pain research
- Genetics
- Cell and molecular biology
Context:
- Chronic pain (hypersensitivity from inflammation or nerve injury) and acute nociceptive pain are distinct conditions requiring different treatments.
- Recent progress in pain research is driven by advances in genetics and molecular biology.
Purpose:
- To review novel targets for analgesia based on recent advances in pain research.
- To discuss the impact of genetic factors on pain sensitivity and modulation.
- To explore potential therapeutic approaches using genetic techniques for pain management.
Summary:
- Novel targets for pain management have been identified at the peripheral nerve level, including tetrodotoxin-resistant sodium channels, vanilloid receptors, and calcium channels.
- Strategies for spinal cord pain control involve blocking excitatory input, enhancing inhibitory control, or a combination of both.
- Identifying mechanisms of hypersensitivity provides multiple targets for developing new analgesics.
Impact:
- Emerging targets offer hope for developing new analgesic drugs with improved efficacy and reduced side effects.
- A deeper understanding of pain mechanisms facilitates the development of more targeted and effective pain therapies.